1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Nasal cavity eosinophilic angiocentric fibrosis: CT and MR imaging characteristics
Patient No. Sex/ Age (years) Location Lesion Size (mm) Unenhanced CT MR Imaging Follow-Up (years)
T1WI T2WI Contrast
1 F/26 Nasal septum 33 Isodense Isointense Hypointense Moderate 2
2 M/16 Nasal septum 52 Isodense Isointense Hypointense Moderate N
3 F/62 Right lateral nasal wall 21 Isodense Isointense Isointense Moderate 4
4 M/28 Nasal septum 26 Isodense N N N 3
5 F/24 Nasal septum 35 Isodense N N N 5
6 M/73 Left lateral nasal wall 12 Isodense N N N 0.5
Note:—Lesion size indicates maximum diameter. CT density and MR imaging signal intensity are compared with cerebral gray matter. N indicates none.
Five patients were followed up for 0.5–5 years following surgery. Patient 1 recurred after 2 years (Fig 3F); the other 5 patients showed no evidence of recurrence. After the second surgery, a follow-up of approximately 1 year for patient 1, there was no clinical evidence of recurrence.